Modular Medical Net Loss History

MODD Stock  USD 0.17  -0.02  -10.53%   
Modular Medical's Net Loss is generally falling. The latest Net Loss reading is -16.1 M, compared with -16.9 M a year ago (down 5.26%). View All Financial Accounts
 
Net Loss  
 First Reported
2004-09-30
 Previous Quarter
-7.8 M
 Current Value
-7.4 M
 Quarterly Volatility
M
Macro event markers
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Modular Medical carries a Net Loss profile shaped by its industry, scale, and capital structure.

Latest Modular Medical's Net Loss Growth Pattern

Modular Medical's Net Loss over the past 15 years is plotted below. A slightly volatile pattern across the series may reflect cyclical or seasonal influences. The interplay between trend direction and volatility shapes the risk profile of this metric. The annual reporting cadence smooths out intra-year noise, revealing the underlying direction. The spread between Modular Medical's highest and lowest reported Net Loss defines the historical envelope.
Net Loss10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Net Loss Trend Statistics

Arithmetic Mean-6,908,614
Coefficient Of Variation-115.75
Mean Deviation 7,159,941
Median-2,539,498
Standard Deviation 7,996,991
Sample Variance64T
Range18.8M
R-Value-0.89
Mean Square Error13.6T
R-Squared 0.80
Slope-1,416,652
Total Sum of Squares1023.2T

Modular Medical Net Loss History

2026-16.1 M
2025-16.9 M
2024-18.8 M
2023-17.5 M
2022-13.9 M
2021-18.6 M
2020-7.4 M
2019-5.3 M
2018-2.5 M
2016-106.6 K
2015-31.1 K
2014-31 K
2013-22.8 K
2012-20.8 K
2011-17.5 K

Methodology, Assumptions & Data Sources

This chart follows Modular Medical's Net Loss across recent years. Revenue and margin trends can explain shifts in this metric.

Reported values for Modular Medical are derived from periodic company reporting and market reference feeds and then standardized for analysis. Refresh timing depends on source availability. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board
Last reviewed on March 4th, 2026